BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:Cancer Research Institute Technology Impact Award
DTSTART;VALUE=DATE:20211115
DTSTAMP:20260428T074749Z
UID:8a3d8e1edff9941762b7bfb2cc332c3664f95774c57c0f12ef52e44c
CATEGORIES:Call for proposal
DESCRIPTION:Aim\nTo address the gap between technology development and cli
 nical application of cancer immunotherapies. These grants aim to encourage
  collaboration between technology developers and clinical cancer immunolog
 ists and to generate the proof-of-principle of a novel platform technology
  in bioinformatics\, ex vivo or in silico modeling systems\, immunolog
 ical or tumor profiling instrumentation\, methods\, reagents and assays\, 
 or other relevant technologies that can enable clinician scientists to gen
 erate deeper insights into the mechanisms of action of effective or ineffe
 ctive cancer immunotherapies.\n\nAward winners will be selected based on t
 he novelty\, creativity\, technical sophistication\, and transformative po
 tential of the technology to impact cancer immunotherapy research around t
 he world. The ultimate aim of this program is to advance technologies that
  can speed up the entire field’s efforts in addressing one of the most d
 efining challenges of our time—developing immunotherapies that are effec
 tive for all cancer patients.\n\nOverview\nThe most competitive applicants
  will address areas where technological innovation stands to benefit the f
 ield and cancer patients most\, and that will ultimately lead to effective
  next generation cancer immunotherapies. These technologies may include bu
 t are not limited to:\n\n	New bioinformatics methods or technologies that 
 speed collection and analysis of large sets of patient-derived biological 
 data\n	Computer simulations for modeling biological systems and responses 
 to immunotherapy\n	Tools and methods that improve profiling of tumors to i
 nform therapeutic strategies\n	Real-time visualizations of molecular and c
 ellular activity to improve tracking of responses to immunotherapy\n	In vi
 tro tissue culture systems that recapitulate the interactions between pri
 mary tumor cells and the immune system\n\n\nAvailable Funding\n\n	$200\,00
 0 USD\n	12 - 24 months\n\nEligibility\n\n\n	Faculty appointment as a tenur
 e-track assistant professor (or higher rank) at the time of award activati
 on\n	Or\, institutional documentation must accompany the Letter of Intent 
 indicating they will hold the position of assistant professor (or higher
  rank) by the time of award activation\n	Joint submissions from collaborat
 ors will also be considered. (The collaborators will share the award.) Eac
 h collaborator must meet the eligibility criteria\n	Selected projects that
  meet their 12 and 24 month milestones may be eligible for follow-on fundi
 ng that will enable the established proof-of-concept technology to be deve
 loped into a methodology that improves cancer immunotherapy research world
 wide\n\nHow to Apply\n\n\n	Technology Impact Award applications are at the
  bottom of the website\n	Please carefully read the application instruction
 s\n\nDeadline\n\n\n	Letter of Intent: 15 November 2021\n	Invitited proposa
 ls: 15 March 2022\n	Announcement of award: 30 June 2022\n	Project reviews 
 at 12 and 24 months\n\nFor addtional information or assistance\n\n\n	Conta
 ct the Research Office at research@epfl.ch\n
LOCATION:
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR